These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31318186)

  • 41. Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.
    Heskamp S; Boerman OC; Molkenboer-Kuenen JD; Wauters CA; Strobbe LJ; Mandigers CM; Bult P; Oyen WJ; van der Graaf WT; van Laarhoven HW
    PLoS One; 2015; 10(2):e0117745. PubMed ID: 25680198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection.
    Oh HS; Eom DW; Kang GH; Ahn YC; Lee SJ; Kim JH; Jang HJ; Kim EJ; Oh KH; Ahn HJ
    Gastric Cancer; 2014; 17(3):402-11. PubMed ID: 23955257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.
    Koh YW; Yoon DH; Suh C; Cha HJ; Huh J
    Int J Exp Pathol; 2015 Aug; 96(4):232-9. PubMed ID: 25916750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer.
    Park JS; Kim HS; Bae YS; Cheong JH; Rha SY; Noh SH; Kim H
    Jpn J Clin Oncol; 2016 Jun; 46(6):507-16. PubMed ID: 27008850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
    Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
    Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.
    Gori S; Sidoni A; Colozza M; Ferri I; Mameli MG; Fenocchio D; Stocchi L; Foglietta J; Ludovini V; Minenza E; De Angelis V; Crinò L
    Ann Oncol; 2009 Apr; 20(4):648-54. PubMed ID: 19188134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
    Czyzewska J; Guzinska-Ustymowicz K; Kemona A
    Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of insulin-like growth factor receptor type 1 correlate with lymphatic metastases in human gastric cancer.
    Gryko M; Kiśluk J; Cepowicz D; Zińczuk J; Kamocki Z; Guzińska-Ustymowicz K; Pryczynicz A; Czyżewska J; Kemona A; Kędra B
    Pol J Pathol; 2014 Jun; 65(2):135-40. PubMed ID: 25119174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?
    Palmerini E; Benassi MS; Quattrini I; Pazzaglia L; Donati D; Benini S; Gamberi G; Gambarotti M; Picci P; Ferrari S
    Orphanet J Rare Dis; 2015 Jan; 10():6. PubMed ID: 25613038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
    Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
    Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.
    Yerushalmi R; Gelmon KA; Leung S; Gao D; Cheang M; Pollak M; Turashvili G; Gilks BC; Kennecke H
    Breast Cancer Res Treat; 2012 Feb; 132(1):131-42. PubMed ID: 21574055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin-like growth factor-1 receptor expression in thymic malignancies.
    Girard N; Teruya-Feldstein J; Payabyab EC; Riely GJ; Rusch VW; Kris MG; Zakowski MF
    J Thorac Oncol; 2010 Sep; 5(9):1439-46. PubMed ID: 20736806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis.
    Shimizu C; Hasegawa T; Tani Y; Takahashi F; Takeuchi M; Watanabe T; Ando M; Katsumata N; Fujiwara Y
    Hum Pathol; 2004 Dec; 35(12):1537-42. PubMed ID: 15619214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab.
    Scartozzi M; Giampieri R; Maccaroni E; Mandolesi A; Giustini L; Silva R; Zaniboni A; Biscotti T; Biagetti S; Galizia E; Loupakis F; Falcone A; Bearzi I; Cascinu S
    Ann Oncol; 2012 Jul; 23(7):1706-12. PubMed ID: 22112971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6-P/IGF 2R).
    Pavelić K; Kolak T; Kapitanović S; Radosević S; Spaventi S; Kruslin B; Pavelić J
    J Pathol; 2003 Nov; 201(3):430-8. PubMed ID: 14595755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer.
    Araki I; Washio M; Yamashita K; Hosoda K; Ema A; Mieno H; Moriya H; Katada N; Kikuchi S; Watanabe M
    Surg Today; 2018 May; 48(5):478-485. PubMed ID: 29256147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy.
    Wu XY; Wu ZF; Cao QH; Chen C; Chen ZW; Xu Z; Li WS; Liu FK; Yao XQ; Li G
    World J Gastroenterol; 2014 Nov; 20(43):16268-74. PubMed ID: 25473182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.
    Makatsoris T; Tsamandas AC; Strimpakos A; Alexopoulou Z; Dionysopoulos D; Pervana S; Konstantara A; Papakostas P; Samantas E; Rallis G; Dimou A; Pentheroudakis G; Papaparaskeva K; Psyrri A; Kalogeras KT; Syrigos K; Scopa CD; Fountzilas G
    Anticancer Res; 2016 Apr; 36(4):1581-90. PubMed ID: 27069134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer.
    Bamias A; Karina M; Papakostas P; Kostopoulos I; Bobos M; Vourli G; Samantas E; Christodoulou Ch; Pentheroudakis G; Pectasides D; Dimopoulos MA; Fountzilas G
    Cancer Chemother Pharmacol; 2010 May; 65(6):1009-21. PubMed ID: 20130877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [HER-2 expression in advanced gastric cancer and its correlation with clinical features, outcome and prognosis].
    Wang Y; Xu JM; Liu JZ; Lin L; Ge FJ; Li SS; Liu LJ; Zhao CH
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):671-5. PubMed ID: 22340047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.